These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 6099738)

  • 1. Plasma enalapril levels and hormonal effects after short- and long-term administration in essential hypertension.
    Johnston CI; Jackson BJ; Larmour I; Cubella R; Casley D
    Br J Clin Pharmacol; 1984; 18 Suppl 2(Suppl 2):233S-239S, 241S. PubMed ID: 6099738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of dietary sodium on angiotensin-converting enzyme (ACE) inhibition and the acute hypotensive effect of enalapril (MK-421) in essential hypertension.
    Jackson B; Cubela R; Johnston CI
    J Hypertens; 1984 Aug; 2(4):371-7. PubMed ID: 6099390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism for hypotensive action of angiotensin converting enzyme inhibitors.
    Johnston CI; Jackson B; Cubela R; Arnolda L
    Clin Exp Hypertens A; 1984; 6(1-2):551-61. PubMed ID: 6199136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of enalapril, enalaprilic acid and captopril in blocking angiotensin I-induced pressor and dipsogenic responses in spontaneously hypertensive rats.
    Gaul SL; Martin GE; Sweet CS
    Clin Exp Hypertens A; 1984; 6(6):1187-206. PubMed ID: 6086183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between angiotensin converting enzyme inhibition and the acute hypotensive response to MK 421 in essential hypertension.
    Jackson B; McGrath BP; Johnston CI
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():99-104. PubMed ID: 6291832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An overview of the clinical pharmacology of enalapril.
    Davies RO; Gomez HJ; Irvin JD; Walker JF
    Br J Clin Pharmacol; 1984; 18 Suppl 2(Suppl 2):215S-229S. PubMed ID: 6099737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
    McCaa RE; Gillespie JB
    Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The acute effects of the new angiotensin I-converting enzyme inhibitor, enalapril maleate, on blood pressure, plasma renin, aldosterone and kinins in hypertensive patients].
    Gotoh M; Mizuno K; Hashimoto S; Kunii N; Fukuchi S
    Nihon Naibunpi Gakkai Zasshi; 1985 May; 61(5):619-29. PubMed ID: 2991035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin converting enzyme during acute and chronic enalapril therapy in essential hypertension.
    Jackson B; Johnston CI
    Clin Exp Pharmacol Physiol; 1984; 11(4):355-9. PubMed ID: 6097377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects.
    Lewis RA; Baker KM; Ayers CR; Weaver BA; Lehman MR
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S12-5. PubMed ID: 2580164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enalaprilat: an intravenous substitute for oral enalapril therapy. Humoral and pharmacokinetic effects.
    Reams GP; Lal SM; Whalen JJ; Bauer JH
    J Clin Hypertens; 1986 Sep; 2(3):245-53. PubMed ID: 3023555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of enalapril, a new converting enzyme inhibitor, in hypertension.
    Ferguson RK; Vlasses PH; Swanson BN; Mojaverian P; Hichens M; Irvin JD; Huber PB
    Clin Pharmacol Ther; 1982 Jul; 32(1):48-53. PubMed ID: 6282527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of antihypertensive effect of enalapril to serum MK-422 levels and angiotensin converting enzyme inhibition.
    Johnston CI; Jackson B; McGrath B; Matthews G; Arnolda L
    J Hypertens Suppl; 1983 Oct; 1(1):71-5. PubMed ID: 6100611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of angiotensin converting enzyme (ACE) in the pharmacokinetics and pharmacodynamics of ACE inhibitors.
    Johnston CI; Jackson B; Cubela R; Larmour I; Arnolda L
    J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S9-14. PubMed ID: 2422495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormonal and metabolic effects of angiotensin converting enzyme inhibitors. Possible differences between enalapril and captopril.
    Atlas SA; Case DB; Yu ZY; Laragh JH
    Am J Med; 1984 Aug; 77(2A):13-7. PubMed ID: 6089554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enalapril and lisinopril in renovascular hypertension--antihypertensive and hormonal effects of two new angiotensin-converting-enzyme (ACE) inhibitors. A preliminary report.
    Karlberg BE; Fyhrquist F; Grönhagen-Riska C; Tikkanen I; Ohman KP
    Scand J Urol Nephrol Suppl; 1984; 79():103-6. PubMed ID: 6089307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enalapril, a nonsulfhydryl angiotensin-converting enzyme inhibitor.
    Vlasses PH; Larijani GE; Conner DP; Ferguson RK
    Clin Pharm; 1985; 4(1):27-40. PubMed ID: 2982541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological properties of the converting enzyme inhibitor, enalapril maleate (MK-421).
    Sweet CS
    Fed Proc; 1983 Feb; 42(2):167-70. PubMed ID: 6295819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enalapril in treatment of hypertension with renal artery stenosis. Changes in blood pressure, renin, angiotensin I and II, renal function, and body composition.
    Hodsman GP; Brown JJ; Cumming AM; Davies DL; East BW; Lever AF; Morton JJ; Murray GD; Robertson JI
    Am J Med; 1984 Aug; 77(2A):52-60. PubMed ID: 6089557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
    Cerasola G; Cottone S; D'Ignoto G; Grasso L; Carone MB; Carapelle E; Contorno A
    Clin Ther; 1987; 9(4):390-9. PubMed ID: 3038326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.